Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic encephalopathy.

E L Rogers1

  • 1Department of Medicine, University of Maryland, School of Medicine, Baltimore.

Critical Care Clinics
|July 1, 1985
PubMed
Summary
This summary is machine-generated.

Hepatic encephalopathy arises from a damaged liver's inability to metabolize toxins, causing neurological symptoms. Prompt treatment of underlying liver issues and precipitating factors is crucial for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of inflammation-related genes in osteoarthritis.

Osteoarthritis and cartilage·2015
Same author

Community partnering and coalition development: finding solutions to oral health care problems together.

Journal of dental education·2001
Same author

Stereotactic breast biopsy: a six-year surgical experience.

The Journal of the Kentucky Medical Association·2001
Same author

Time for medical education reform.

Academic medicine : journal of the Association of American Medical Colleges·1996
Same author

Cultural and organizational implications of academic managed-care networks.

The New England journal of medicine·1994
Same author

Breast conservation versus mastectomy: patient preferences in a community practice in Kentucky.

Journal of surgical oncology·1993
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Area of Science:

  • Hepatology
  • Neurology
  • Toxicology

Background:

  • Hepatic encephalopathy (HE) is a complex neuropsychiatric complication of liver dysfunction.
  • It is characterized by a spectrum of neurological and psychiatric abnormalities.
  • The accumulation of toxic byproducts, due to impaired hepatic metabolism, is central to HE pathogenesis.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms of hepatic encephalopathy.
  • To highlight the neurological manifestations of HE.
  • To outline current therapeutic strategies for managing HE.

Main Methods:

  • Review of existing literature on hepatic encephalopathy.
  • Analysis of the biochemical pathways involved in toxin metabolism.

Related Experiment Videos

  • Correlation of metabolic disturbances with neurological deficits.
  • Main Results:

    • Impaired liver function leads to the buildup of neurotoxic substances.
    • These toxins disrupt normal neurotransmission, resulting in altered mental status, confusion, and potentially coma.
    • Additional metabolic stressors exacerbate neurological deficits in patients with HE.

    Conclusions:

    • Hepatic encephalopathy is a direct consequence of the liver's failure to detoxify specific metabolic products.
    • Effective management necessitates vigilant monitoring and aggressive treatment of precipitating factors and the underlying liver disease.
    • Addressing both the hepatic dysfunction and the encephalopathy itself is key to patient care.